Kingfisher PLC reported a 0.7% decline in underlying like-for-like sales for the first quarter ending April 30, impacted by poor weather and a late spring affecting footfall and seasonal demand. Despite this, total sales rose 1.4% to £3.3 billion, with Screwfix outperforming and gaining market share in the UK and Ireland. Trade and online sales also showed strong growth. The company reaffirmed its full-year adjusted pre-tax profit guidance of £565-625 million, signaling confidence in its strategy and market position amid challenging conditions.
SpaceX's upcoming IPO may cause forced ETF buying of $22-$27 billion as Nasdaq changes rules to fast-track the company's index inclusion. The Nasdaq 100 now allows new companies to join within 15 days if their market cap ranks in the top 40, removing...
The global Bioprocess Automation Software market, valued at $1.67 billion in 2025, is projected to grow to $6.19 billion by 2035 at a 14% CAGR. This growth is fueled by the increasing demand for personalized medicine, flexible manufacturing processes...
The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...
Hyperliquid has expanded its decentralized exchange to include HIP-4 outcome markets, allowing users to trade prediction contracts on offchain macro events like U.S. inflation and Federal Reserve decisions. Unlike Polymarket, which uses an external o...
Poolbeg Pharma received positive feedback from the FDA during a pre-IND meeting for its lead cancer therapy candidate, POLB 001, aimed at preventing cytokine release syndrome (CRS), a side effect of cancer immunotherapy. The FDA broadly agreed with P...
